Immunology and immunotherapy of cholangiocarcinoma
Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
the Western world but is rising globally. Surgery, chemotherapy and radiation therapy have …
Current epidemiology in hepatocellular carcinoma
P Konyn, A Ahmed, D Kim - Expert review of gastroenterology & …, 2021 - Taylor & Francis
Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …
leading cause of cancer-related mortality in the world. Areas covered This review will …
[HTML][HTML] Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease
F Åberg, CD Byrne, CJ Pirola, V Männistö… - Journal of …, 2023 - Elsevier
Alcohol use and metabolic syndrome are highly prevalent in the population and frequently
co-exist. Both are implicated in a large range of health problems, including chronic liver …
co-exist. Both are implicated in a large range of health problems, including chronic liver …
NAFLD‐related hepatocellular carcinoma: The growing challenge
PA Shah, R Patil, SA Harrison - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …
morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the …
Cholangiocarcinoma: Epidemiology and risk factors
Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction
between host‐specific genetic background and multiple risk factors. Globally, CCA …
between host‐specific genetic background and multiple risk factors. Globally, CCA …
Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
NN Massarweh, HB El-Serag - Cancer control, 2017 - journals.sagepub.com
Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most
frequently occurring types of primary liver cancer and together are among the most common …
frequently occurring types of primary liver cancer and together are among the most common …
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of …
JM Banales, V Cardinale, G Carpino… - Nature reviews …, 2016 - research.ed.ac.uk
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of
biliary tract differentiation. CCA is the second most common primary liver tumour and the …
biliary tract differentiation. CCA is the second most common primary liver tumour and the …
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment
Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading
cause of cancer mortality worldwide. Incidence rates of liver cancer vary widely between …
cause of cancer mortality worldwide. Incidence rates of liver cancer vary widely between …
Cholangiocarcinoma: current knowledge and new developments
B Blechacz - Gut and liver, 2016 - pmc.ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is
more common in Asia, its incidence in Europe and North America has significantly increased …
more common in Asia, its incidence in Europe and North America has significantly increased …